期刊文献+

纳米粒沉淀法制备阳离子载基因PLA-PEG纳米粒 被引量:5

Preparation of cationic gene loaded PLA-PEG nanoparticles by nanoprecipitation method
下载PDF
导出
摘要 目的建立纳米粒沉淀法制备阳离子PLA-PEG纳米粒的方法。方法采用单因素设计考察不同影响因素对纳米粒粒径大小的影响,在单因素考察的基础上采用正交设计优化处方,制备了粒径较小,正电荷适中的阳离子PLA-PEG纳米粒。并对纳米粒的物理性质如物理形态,平均粒径,粒度分布,Zeta电位,DNA结合率,体外细胞转染能力等进行了考察。结果采用纳米粒沉淀法,通过优化处方和工艺制得的纳米粒外观圆整,呈类球形,大小均匀,平均粒径为89.7 nm,粒径分布指数为0.185,表面荷较高的正电荷,Zeta电位为+28.9 mV,能够高效的结合DNA且能够成功的转染Hela细胞。结论优化确定了纳米粒沉淀法制备阳离子PLA-PEG纳米粒的处方和工艺,可以制备满足细胞转染要求的阳离子载基因纳米粒。 Purpose To develop a nanoprecipitation method for preparation of cationic PLA-PEG nanoparticles(PLA-PEG-NPs). Methods The effects of different formulations and technical factors on the particle size of nanoparticles were investigated by single factor investigation. Based on single factor investigation, the formulation was optimized by orthogonal design. The optimal nanoparticles were characterized in terms of morphology, average particle size, polydispersion index (PDI), Zeta potential, DNA binding efficiency and in vitro cell transfection capability. Results The nanoparticles prepared by nanoprecipitation method were spherical in shape with average particle size of 89.7 nm, uniform in size with PDI of 0. 185, and positive in surface with Zeta potentials of + 28.9 mV. The obtained PLA-PEG-NPs could bind efficiently with DNA onto its sur-face and successfully transfer Hela cells. Conclusion A nanoprecipitation method was optimized to manufacture gene loaded cationic PLA-PEG nanopartieles with excellent characteristics meeting cell transfection requirements.
作者 邹伟伟 张娜
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2009年第1期1-5,共5页 Chinese Journal of Biochemical Pharmaceutics
基金 国家自然科学基金资助项目(30572267)
关键词 纳米粒沉淀法 PLA-PEG纳米粒 非病毒基因载体 制备 nanoprecipitation method PLA-PEG nanoparticles non-viral gene vector preparation
  • 相关文献

参考文献13

  • 1Vasir J K, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics[J]. Adv Drug Deliv Rev,2007,59(8) :718-728.
  • 2Mundargi R C, Babu V R, Rangaswamy V, et al. Nano/micro technologies for delivering macromolecular therapeutics using poly ( D, L-lactide-co-glycolide) and its derivatives [ J]. J Controlled Release, 2008, 125(3) : 193-209.
  • 3Eley J G, Mathew P. Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles[J]. J Microencapsul, 2007,24( 3 ) : 225-234-.
  • 4Abeylath S C, Turos E. Glycosylated polyacrylate nanoparticles by emulsion polymerization [ J ]. Carbohydr Polym, 2007,70 ( 1 ) : 32-37.
  • 5Legrand P, Lesieur S, Bochot A, et al. Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nano- precipitation[J]. Int J Pharm,2007,344(1-2) :33-43.
  • 6McCarron P A, Donnelly R F, Marouf W. Celecoxib-loaded poly( D, L- lactide-co-glycolide) nanoparticles prepared using a novel and control- lable combination of diffusion and emulsification steps as part of the salting-out procedure[J] .J Microencapsul,2006,23(5) :480-498.
  • 7Quintanar-Guerrero D, All,mann E, Fessl H, et al. Preparation techniques and mechanisms of formation of biodegradable nanopartieles from preformed polymers [ J ] . Drug Dev Ind Pharm, 1998,24 (12) : 1113- 1128.
  • 8Bilati U, Allemann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles [ J ]. Eur J Pharm Sci, 2005,24( 1 ) : 67-75.
  • 9Prabha S, Zhou W Z, Panyam J, et al. Size-dependency of nanoparticlemediated gene transfection : studies with fractionated nanopartieles [ J ] .Int J Pharm,2002,244(1-2):105-115.
  • 10Oster C G, Wittmar M, Bakowsky U, et al. DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method[ J ]. J Controlled Release, 2006,111 ( 3 ) : 371-381.

同被引文献103

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部